NorthWest Biotherapeutics Inc (NWBO)

[koman]

How about this quiz:

1) What percentage of nGBM patients randomized into the main trial are psPD (this includes radionecrosis)?
a) 10%
b) 15%
c) 20%
d) 30%

2) How will these psPD patients affect the medPFS?
a) lower it
b) raise it
c) do neither

3) Did Dr. Bosch's statement that pseudoprogression is wreaking havoc on trials refer to this p3 dcvax-L trial?
a) Yes
b) No

4) Did the pI trial results for medPFS showing 24mth reflect a correction for psPD that will NOT be utilized in this p3 trial?
a) Yes
b) NO

5) Will Baseline 1 MRI be able to capture enough psPD patients to meet the 32 enrollment number for the psPD randomized arm?
a) Yes
b) NO